In addition, MACROD2 deletion in CRC is significantly associated with the extent of malignancy, indicating that MACROD2 acts as a haploin-sufficient tumor suppressor, with the loss of function promoting chromosome instability and thereby driving cancer evolution. Here, MACROD2 is linked to colorectal carcinoma.